Drawing for SARCONEOS

USPTO serial 79207745

SARCONEOS

Reviewed by CopyMark Law Group

Reg. 5398665Status 709
Filing date
Status date
Registration date
Feb 13, 2018
Examiner
LE, KHANH M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SARCONEOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cynthia A. Moyer

Cynthia A. Moyer Fredrikson & Byron, P.A.200 South Sixth StreetSuite 4000Minneapolis, MN 55402

Goods and services

ClassDescriptionStatusFirst use
003Soaps, namely, perfumed soaps, beauty soaps, shaving soaps, bath soaps, cosmetic soaps; perfumes, essential oils, cosmetics, hair lotions; slimming cosmetic preparations for external useSECTION 71 - CANCELLED—
005Pharmaceutical products for the prevention and treatment of muscular diseases, namely, sarcopenia, cachexies, genetic muscular diseases; pharmaceutical products for the prevention and treatment of metabolic diseases, namely, diabetes, obesity and cardiovascular diseases; dietetic substances, namely, capsules, tablets, bars, sachets, liquids, jellies, powders based of amino acids, minerals, mineral salts, vitamins, proteins to prevent the oxidation of the body, the cardiovascular diseases, to improve vision, to improve the articular flexibility, to promote relaxation, to strengthen the immune systems and foods for medical use; food supplements for human beings; sanitary products for medical purposes, namely, medicinal astringents, disinfectants for medical instruments, medicated body care soaps, disinfectant soaps, medicated personal soaps, antifungal creams for medical use, medicated lotions for the body and shampoos without rinsing, rubbing alcohol for medical use, medicated skin cleansers for medical use; medical plasters; materials for medical dressings, namely, bandages, dressings and medical gauzes, absorbent cotton for bandages, bands and strips for bandages; material for stopping teeth and for dental impressions; disinfectants; preparations for destroying vermin; fungicides; herbicides; medicated baths preparations; sanitary pads, panties or towels; chemical preparations for pharmaceutical use, namely, preventive pharmaceutical agents for cerebral hemorrhage, release agents of medicines in the form of edible wafers for the conditioning of pharmaceutical products in the form of powder, medicated pharmaceutical astringents; parasiticides; dietetic sugar for medical use; alloys of precious metals for dental use; dietetic substances for medical use produced by organic farming or made with goods produced by organic farming, namely, supplements with extracts of plants for the treatment of muscle diseases, namely sarcopenia, cachexia, genetic muscular dystrophies, metabolic diseases, namely, diabetes, obesity and cardiovascular diseases; food for babiesSECTION 71 - CANCELLED—
042Evaluations, assessments and research in the fields of science and technology provided by engineers; research and development of new products for others; technical project studies in scientific and technologic fields, namely, feasibility studies in the field of new technologies; technological studies in the field of pharmaceutical research and development; technical research in the field of pharmaceutical research and development; research in the field of pharmaceutical products; biological, medical research services; clinical research in the field of pharmaceuticals; biotechnological research; scientific research for medical purposes; computer-aided scientific research services; information relating to scientific research; preparation of reports relating to scientific research; advice relating to research and development in the therapeutic field of pharmaceuticals; providing information and data relating to medical and veterinary research and development; design and development of computers and software; installation, maintenance and updating or rental of software; programming for computers; consultancy relating to computers; conversion of computer programs and data other than physical conversion; conversion of documents from a physical medium to an electronic mediumSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 30, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 5, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 16, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 16, 2025INPCINVALIDATION PROCESSED—
Apr 30, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 30, 2024C71TCANCELLED SECTION 71—
Feb 13, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 29, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 17, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 17, 2018FIMPFINAL DISPOSITION PROCESSED—
May 13, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 13, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 9, 2017GPNXNOTIFICATION PROCESSED BY IB—
Nov 28, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 28, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 22, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 22, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 8, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 26, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 14, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 14, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 14, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 11, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 11, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 11, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 21, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 20, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 20, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2017RFNTREFUSAL PROCESSED BY IB—
Jun 9, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 9, 2017RFRRREFUSAL PROCESSED BY MPU—
May 27, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 27, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
May 26, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2017DOCKASSIGNED TO EXAMINER—
May 23, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 18, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance